Current in vitro assays have significant limitations in predicting oral bioavailability of food-derived bioactive peptides, and advanced mass spectrometry techniques are needed to track peptides through digestion and absorption.
Significant gapscurrent assays inadequately predict whether food-derived bioactive peptides reach the bloodstream in active form
What the researchers found
Current in vitro permeability assays have limitations in predicting oral bioavailability of food-derived bioactive peptides. Advanced mass spectrometry and peptidomics are needed to detect individual peptides from complex hydrolysates in biological samples.
Why it matters
The bioactive peptide supplement industry is growing rapidly, but much of the evidence relies on in vitro studies. Without better bioavailability measurements, it's difficult to know which food-derived peptides actually deliver health benefits when consumed orally.
The numbers in context
In vitro assays poorly predict absorption; blood levels of food peptides very low in animal and human studies.
How the study worked
Critical review of in vitro digestion assays, permeation models, and metabolism studies as predictors of oral bioavailability. Discussion of analytical challenges and potential improvements.
Who was studied
Food-derived protein hydrolysates and bioactive peptides across multiple bioavailability studies
What this study cannot tell us
Review identifies problems but doesn't provide definitive solutions. The relationship between detectable blood levels and biological activity remains poorly defined. Standardization of bioavailability methods is lacking.
How to read the evidence
Critical methodological review identifying limitations in current research approaches. Important for interpreting the bioactive peptide literature.
When this study was published
Published in 2021. Peptidomics and mass spectrometry capabilities continue to advance, addressing some identified gaps.
The bigger picture
As collagen peptides, whey peptides, and other food-derived bioactive peptides gain consumer popularity, rigorous science demonstrating their actual bioavailability becomes essential for distinguishing effective products from marketing claims.
Questions still open
- Can peptidomics approaches solve the analytical challenge of tracking food peptides through digestion?
- What minimum blood concentration of a bioactive peptide is needed for a health effect?
- Should regulatory frameworks require bioavailability data for bioactive peptide health claims?
Common questions
Do collagen peptides actually get absorbed when you take them orally?
Why is peptide bioavailability so hard to measure?
Read the original research
Measuring the oral bioavailability of protein hydrolysates derived from food sources: A critical review of current bioassays.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 144, 112275
Citation
Abeer, Muhammad Mustafa; Trajkovic, Sanja; Brayden, David J. (2021). Measuring the oral bioavailability of protein hydrolysates derived from food sources: A critical review of current bioassays.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 144, 112275. https://doi.org/10.1016/j.biopha.2021.112275